A Supramolecular Approach to Structure-Based Design with A Focus on Synthons Hierarchy in Ornithine-Derived Ligands: Review, Synthesis, Experimental and in Silico Studies.

C-H…π C=O (lone pair)…π and N-O…π interactions DFT H-bond energies ProTox II. SwissADME drug-likeness electrostatic molecular potential molecular (Hirshfeld) surface ornithine supramolecular synthon π…π

Journal

Molecules (Basel, Switzerland)
ISSN: 1420-3049
Titre abrégé: Molecules
Pays: Switzerland
ID NLM: 100964009

Informations de publication

Date de publication:
03 Mar 2020
Historique:
received: 31 01 2020
revised: 20 02 2020
accepted: 02 03 2020
entrez: 7 3 2020
pubmed: 7 3 2020
medline: 15 12 2020
Statut: epublish

Résumé

The success of innovative drugs depends on an interdisciplinary and holistic approach to their design and development. The supramolecular architecture of living systems is controlled by non-covalent interactions to a very large extent. The latter are prone to extensive cooperation and like a virtuoso play a symphony of life

Identifiants

pubmed: 32138329
pii: molecules25051135
doi: 10.3390/molecules25051135
pmc: PMC7179192
pii:
doi:

Substances chimiques

Ornithine E524N2IXA3

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.

Références

Eur J Appl Physiol. 2011 Nov;111(11):2837-43
pubmed: 21431425
J Med Chem. 2002 Jun 6;45(12):2615-23
pubmed: 12036371
Nucleic Acids Res. 2014 Jul;42(Web Server issue):W53-8
pubmed: 24838562
J Biol Chem. 2006 May 26;281(21):14529-32
pubmed: 16459331
Acta Crystallogr B Struct Sci Cryst Eng Mater. 2016 Apr;72(Pt 2):171-9
pubmed: 27048719
Chem Commun (Camb). 2007 Oct 7;(37):3814-6
pubmed: 18217656
ChemMedChem. 2016 Jun 6;11(11):1117-21
pubmed: 27218427
J Young Pharm. 2012 Jul;4(3):184-92
pubmed: 23112538
Life Sci. 1973 Dec 16;13(12):1635-47
pubmed: 4591188
Sci Adv. 2016 May 27;2(5):e1600192
pubmed: 27386545
J Chem Inf Model. 2014 Dec 22;54(12):3284-301
pubmed: 25382374
BMC Biotechnol. 2013 Jun 01;13:47
pubmed: 23725060
Pol Przegl Chir. 1967 Sep;39(9):863-70
pubmed: 6063769
Angew Chem Int Ed Engl. 2019 Nov 18;58(47):16780-16784
pubmed: 31385643
Molecules. 2019 Jul 29;24(15):
pubmed: 31362455
J Med Chem. 2010 Jul 22;53(14):5061-84
pubmed: 20345171
J Alzheimers Dis. 2018;62(4):1767-1775
pubmed: 29614679
Pharm Res. 2002 Oct;19(10):1446-57
pubmed: 12425461
Biopolymers. 2000;55(3):227-50
pubmed: 11074417
J Control Release. 2019 Sep 28;310:74-81
pubmed: 31415830
J Am Chem Soc. 2001 Sep 12;123(36):8667-77
pubmed: 11535071
Nucleic Acids Res. 2016 Jan 4;44(D1):D27-37
pubmed: 26615188
PLoS One. 2017 Dec 14;12(12):e0189044
pubmed: 29240775
Arch Biochem Biophys. 1964 Sep;107:499-503
pubmed: 14234500
J Med Chem. 2015 May 14;58(9):4066-72
pubmed: 25860834
Anticancer Drugs. 2016 Jul;27(6):508-18
pubmed: 26918391
J Med Chem. 1978 Jan;21(1):50-5
pubmed: 619149
Chem Rev. 2016 Mar 9;116(5):2775-825
pubmed: 26840650
Biology (Basel). 2017 Mar 07;6(1):
pubmed: 28272331
Front Cell Infect Microbiol. 2019 Feb 14;9:9
pubmed: 30838177
J Surg Res. 2002 Aug;106(2):299-302
pubmed: 12175982
J Enzyme Inhib Med Chem. 2015 Jun;30(3):345-53
pubmed: 24939101
Nucleic Acids Res. 2019 Jan 8;47(D1):D464-D474
pubmed: 30357411
Acta Crystallogr B. 2002 Jun;58(Pt 3 Pt 1):380-8
pubmed: 12037359
Clin Dermatol. 2009 Sep-Oct;27(5):485-94
pubmed: 19695481
Mini Rev Med Chem. 2018;18(12):1008-1021
pubmed: 28971766
Spectrochim Acta A Mol Biomol Spectrosc. 2015 Feb 5;136 Pt B:700-6
pubmed: 25448969
Acta Crystallogr B. 2007 Jun;63(Pt 3):505-9
pubmed: 17507764
CNS Oncol. 2018 Apr;7(2):CNS16
pubmed: 29378419
Int J Mol Sci. 2019 Jun 06;20(11):
pubmed: 31174387
Proc Natl Acad Sci U S A. 2019 Mar 12;116(11):5077-5085
pubmed: 30804204
Nucleic Acids Res. 2020 Jan 8;48(D1):D335-D343
pubmed: 31691821
Acta Crystallogr D Biol Crystallogr. 2009 Feb;65(Pt 2):148-55
pubmed: 19171970
Med Sci (Basel). 2018 Feb 08;6(1):
pubmed: 29419804
J Am Chem Soc. 2017 Oct 11;139(40):13960-13968
pubmed: 28926241
Farmaco. 2001 Jan-Feb;56(1-2):145-8
pubmed: 11347958
Sci Rep. 2017 Mar 03;7:42717
pubmed: 28256516
Adv Drug Deliv Rev. 2001 Mar 1;46(1-3):3-26
pubmed: 11259830
Sci Rep. 2015 Oct 07;5:14738
pubmed: 26443277
Int J Pept Protein Res. 1983 Aug;22(2):154-60
pubmed: 6618759
Eur J Med Chem. 2018 Jan 1;143:1277-1300
pubmed: 29126724
Ther Adv Drug Saf. 2013 Feb;4(1):5-7
pubmed: 25083246
Acta Crystallogr D Struct Biol. 2017 Mar 1;73(Pt 3):240-245
pubmed: 28291759
Acta Crystallogr C Struct Chem. 2015 Jan;71(Pt 1):3-8
pubmed: 25567568
Pharmaceutics. 2019 Jun 20;11(6):
pubmed: 31226856
Appl Microbiol Biotechnol. 2012 Jul;95(1):169-78
pubmed: 22370950
Clin Transl Med. 2018 Jan 17;7(1):3
pubmed: 29340951
Future Oncol. 2017 Apr;13(9):809-819
pubmed: 28125906
Sci Rep. 2018 Sep 27;8(1):14445
pubmed: 30262852
J Chem Inf Comput Sci. 2004 May-Jun;44(3):1000-5
pubmed: 15154768
Nutr J. 2014 Jun 03;13:53
pubmed: 24889392
Adv Drug Deliv Rev. 2002 Mar 31;54(3):273-89
pubmed: 11922948
Proteins. 2004 Feb 1;54(2):247-59
pubmed: 14696187
J Gen Microbiol. 1970 Feb;60(2):159-65
pubmed: 4922668
Ann Pharm Fr. 2014 Jul;72(4):238-43
pubmed: 24997885
Struct Dyn. 2019 Aug 28;6(5):054301
pubmed: 31489338
J Comb Chem. 1999 Jan;1(1):55-68
pubmed: 10746014
J Med Chem. 1988 Jul;31(7):1332-7
pubmed: 3385730
Biochemistry. 1999 Nov 16;38(46):15174-84
pubmed: 10563800
Chem Biol Drug Des. 2018 Feb;91(2):380-390
pubmed: 28816025
Expert Opin Drug Metab Toxicol. 2006 Oct;2(5):715-31
pubmed: 17014391
J Biol Chem. 2003 Jun 13;278(24):22037-43
pubmed: 12672797
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Acta Crystallogr B. 2004 Dec;60(Pt 6):627-68
pubmed: 15534375
Eur J Pharm Sci. 2017 Jan 1;96:571-577
pubmed: 27810561
Pharmacol Rev. 2013 Dec 31;66(1):334-95
pubmed: 24381236
Clin Cancer Res. 1999 May;5(5):945-51
pubmed: 10353725
Biochem Biophys Res Commun. 2019 May 14;512(4):712-715
pubmed: 30926170
J Med Chem. 2001 Jun 7;44(12):1841-6
pubmed: 11384230
Anticancer Agents Med Chem. 2019;19(7):842-874
pubmed: 30657048
Nucleic Acids Res. 2018 Jul 2;46(W1):W257-W263
pubmed: 29718510
Amino Acids. 2008 May;34(4):617-33
pubmed: 18180869
J Med Chem. 2000 Oct 19;43(21):3867-77
pubmed: 11052792
Front Chem. 2019 Feb 18;7:71
pubmed: 30834243
Nutr Res. 2008 Nov;28(11):738-43
pubmed: 19083482
Biotechnol Bioeng. 2009 Nov 1;104(4):651-62
pubmed: 19714672
J Comput Chem. 2003 Apr 30;24(6):669-81
pubmed: 12666158
Front Chem. 2014 Jan 10;1:42
pubmed: 24790970

Auteurs

Joanna Bojarska (J)

Institute of General and Ecological Chemistry, Faculty of Chemistry, Lodz University of Technology, Żeromskiego 116, 90-924 Lodz, Poland.

Milan Remko (M)

Remedika, Sustekova, 1 85104 Bratislava, Slovakia.

Martin Breza (M)

Department of Physical Chemistry, Slovak Technical University, Radlinskeho 9, SK-81237 Bratislava, Slovakia.

Izabela D Madura (ID)

Warsaw University of Technology, Faculty of Chemistry, Noakowskiego, 3 00-664 Warszawa, Poland.

Krzysztof Kaczmarek (K)

Institute of Organic Chemistry, Lodz University of Technology, Faculty of Chemistry, Żeromskiego 116, 90-924 Lodz, Poland.

Janusz Zabrocki (J)

Institute of Organic Chemistry, Lodz University of Technology, Faculty of Chemistry, Żeromskiego 116, 90-924 Lodz, Poland.

Wojciech M Wolf (WM)

Institute of General and Ecological Chemistry, Faculty of Chemistry, Lodz University of Technology, Żeromskiego 116, 90-924 Lodz, Poland.

Articles similaires

Humans Recurrence Male Female Middle Aged

Real world data on cervical cancer treatment patterns, healthcare access and resource utilization in the Brazilian public healthcare system.

Thabata Martins Ferreira Campuzano, Maria Amelia Carlos Souto Maior Borba, Paula de Mendonça Batista et al.
1.00
Humans Female Uterine Cervical Neoplasms Brazil Middle Aged

Scalable ultrastrong MXene films with superior osteogenesis.

Sijie Wan, Ying Chen, Chaojie Huang et al.
1.00
Osteogenesis Animals Tensile Strength Titanium Mice
Humans Female Breast Neoplasms Retrospective Studies Middle Aged

Classifications MeSH